Authors: Aszalos, A Ladanyi, A Bocsi, J Szende, B

Citation: A. Aszalos et al., Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators, CANCER LETT, 167(2), 2001, pp. 157-162

Authors: Ibrahim, S Peggins, J Knapton, A Licht, T Aszalos, A

Citation: S. Ibrahim et al., Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation, ANTICANC R, 21(2A), 2001, pp. 847-856

Authors: Ibrahim, S Peggins, J Knapton, A Licht, T Aszalos, A

Citation: S. Ibrahim et al., Influence of antipsychotic, antiemetic, and Ca2+ channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation, J PHARM EXP, 295(3), 2000, pp. 1276-1283

Authors: Szabo, D Szabo, G Ocsovszki, I Aszalos, A Molnar, J

Citation: D. Szabo et al., Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo, CANCER LETT, 139(1), 1999, pp. 115-119

Authors: Aszalos, A Thompson, K Yin, JJ Ross, DD

Citation: A. Aszalos et al., Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and onP-glycoprotein (Pgp), ANTICANC R, 19(2A), 1999, pp. 1053-1064